GB0019272D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0019272D0
GB0019272D0 GBGB0019272.4A GB0019272A GB0019272D0 GB 0019272 D0 GB0019272 D0 GB 0019272D0 GB 0019272 A GB0019272 A GB 0019272A GB 0019272 D0 GB0019272 D0 GB 0019272D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0019272.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symphar SA
Original Assignee
Symphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphar SA filed Critical Symphar SA
Priority to GBGB0019272.4A priority Critical patent/GB0019272D0/en
Publication of GB0019272D0 publication Critical patent/GB0019272D0/en
Priority to JP2002517041A priority patent/JP2004505908A/en
Priority to AU2002212117A priority patent/AU2002212117A1/en
Priority to CNA018150748A priority patent/CN1561219A/en
Priority to PCT/EP2001/008676 priority patent/WO2002011704A2/en
Priority to KR10-2003-7001509A priority patent/KR20030043923A/en
Priority to CA002417606A priority patent/CA2417606A1/en
Priority to EP01980218A priority patent/EP1326618A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
GBGB0019272.4A 2000-08-04 2000-08-04 Pharmaceutical compounds Ceased GB0019272D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0019272.4A GB0019272D0 (en) 2000-08-04 2000-08-04 Pharmaceutical compounds
JP2002517041A JP2004505908A (en) 2000-08-04 2001-07-27 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
AU2002212117A AU2002212117A1 (en) 2000-08-04 2001-07-27 Use of aryl-substituted 1, 1-diphosphonates for the treatment of bone diseases
CNA018150748A CN1561219A (en) 2000-08-04 2001-07-27 Pharmaceutical compounds
PCT/EP2001/008676 WO2002011704A2 (en) 2000-08-04 2001-07-27 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
KR10-2003-7001509A KR20030043923A (en) 2000-08-04 2001-07-27 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone disease
CA002417606A CA2417606A1 (en) 2000-08-04 2001-07-27 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
EP01980218A EP1326618A2 (en) 2000-08-04 2001-07-27 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019272.4A GB0019272D0 (en) 2000-08-04 2000-08-04 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0019272D0 true GB0019272D0 (en) 2000-09-27

Family

ID=9897063

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0019272.4A Ceased GB0019272D0 (en) 2000-08-04 2000-08-04 Pharmaceutical compounds

Country Status (8)

Country Link
EP (1) EP1326618A2 (en)
JP (1) JP2004505908A (en)
KR (1) KR20030043923A (en)
CN (1) CN1561219A (en)
AU (1) AU2002212117A1 (en)
CA (1) CA2417606A1 (en)
GB (1) GB0019272D0 (en)
WO (1) WO2002011704A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003232108A1 (en) * 2002-05-11 2003-11-11 Ilex Products, Inc. 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
EP1802641B8 (en) 2004-10-08 2012-03-07 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US8012949B2 (en) 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
WO2007109585A2 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
CN101679466A (en) * 2007-04-12 2010-03-24 伊利诺伊大学评议会 Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GPPS, and DPPS
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
WO2016063297A1 (en) 2014-10-21 2016-04-28 Council Of Scientific & Industrial Research Alkylidene phosphonate esters as p-glycoprotein inducers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675422A5 (en) * 1988-03-31 1990-09-28 Symphar Sa
JPH0377894A (en) * 1989-08-18 1991-04-03 Toray Ind Inc Methylene diphosphonic acid compound
US5204336A (en) * 1990-09-13 1993-04-20 Symphar S.A. Naphthyl-,tetrahydronaphthyl-, and indanyl-substituted G-em-diphosphonates and process of use to treat hyperlipidemia
WO1994001442A1 (en) * 1992-07-10 1994-01-20 Toray Industries, Inc. Methanediphosphonate derivative, production thereof, and pharmaceutical use thereof
CH690163A5 (en) * 1995-07-28 2000-05-31 Symphar Sa Derivatives substituted gem-diphosphonates useful as anti-cancer.
US5994329A (en) * 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption

Also Published As

Publication number Publication date
AU2002212117A1 (en) 2002-02-18
EP1326618A2 (en) 2003-07-16
CA2417606A1 (en) 2002-02-14
WO2002011704A2 (en) 2002-02-14
WO2002011704A3 (en) 2002-07-18
CN1561219A (en) 2005-01-05
JP2004505908A (en) 2004-02-26
KR20030043923A (en) 2003-06-02

Similar Documents

Publication Publication Date Title
GB0006133D0 (en) Novel pharmaceutical
GB0020691D0 (en) Pharmaceutical combination
GB0025473D0 (en) Pharmaceutical combinations
GB0031084D0 (en) Pharmaceutical compounds
GB0101225D0 (en) Pharmaceutical compounds
GB0101227D0 (en) Pharmaceutical compounds
GB0012291D0 (en) Pharmaceutical combination
GB0019272D0 (en) Pharmaceutical compounds
GB0019228D0 (en) Novel pharmaceutical
GB0021865D0 (en) Novel pharmaceutical
GB0024318D0 (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB0019224D0 (en) Novel pharmaceutical
GB0019226D0 (en) Novel pharmaceutical
GB0005366D0 (en) Pharmaceutical compounds
GB0021487D0 (en) Pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
HRP20030067A2 (en) Novel pharmaceutical
GB0021785D0 (en) Novel Pharmaceutical
GB0023970D0 (en) Novel pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
GB0105595D0 (en) Pharmaceutical compounds
GB0012534D0 (en) Pharmaceutical compounds
GB0022520D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)